Ake­so lead­er­ship is push­ing back on some of the ques­tions about its next-gen­er­a­tion can­cer drug raised ear­li­er this month at the an­nu­al Amer­i­can So­ci­ety of Clin­i­cal...

Epi­crispr Biotech­nolo­gies on Fri­day shared an ear­ly cut of da­ta from its study of an epi­ge­net­ic edit­ing ther­a­py for a ge­net­ic dis­ease that leads to...

Bay Area biotech Ly­cia Ther­a­peu­tics is re­fu­el­ing with $75 mil­lion for its pro­tein degra­da­tion plat­form co-found­ed by No­bel lau­re­ate Car­olyn Bertozzi.

The com­pa­ny snagged the...

Bio­gen has paused or can­celed in­vest­ment in the “ma­jor­i­ty” of re­search pro­grams that came with its $5.6 bil­lion ac­qui­si­tion of Apel­lis Phar­ma­ceu­ti­cals and laid off...